Mark Wainstein
Payments from drug & device makers
Across 126 payments — averaging $37.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Endo Pharmaceuticals Inc.$534
- Intuitive Surgical$416
- AbbVie$262
- Myovant Sciences Inc.$206
- Medtronic$198
- plus $1K from 22 others
What the payments were for
- Travel & lodging$1,52932%
- Food & beverage$3,22768%
- Education$241%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 17 | $1,929 |
| Endo Pharmaceuticals Inc. | 43 | $534 |
| Intuitive Surgical | 3 | $416 |
| AbbVie(2 entities) | 8 | $262 |
| Myovant Sciences Inc. | 6 | $206 |
| Medtronic(2 entities) | 4 | $198 |
| Astellas Pharma US Inc | 9 | $173 |
| Myriad Genetic Laboratories, Inc. | 5 | $149 |
| Bluewind Medical | 1 | $147 |
| Laborie Medical Technologies Corp. | 4 | $119 |
| Conmed Corporation | 1 | $105 |
| Calyxo, Inc. | 1 | $82 |
| Teleflex LLC | 3 | $73 |
| Sumitomo Pharma America, Inc. | 3 | $63 |
| Sanofi | 2 | $43 |
| Endo USA, Inc. | 2 | $37 |
| KARL Storz Endoscopy-america | 1 | $28 |
| Olympus America Inc. | 1 | $28 |
| Accord Healthcare, Inc. | 1 | $25 |
| Bayer | 1 | $24 |
| Siemens Medical Solutions USA, Inc. | 1 | $24 |
| BD | 1 | $23 |
| Dornier Medtech America, Inc | 1 | $22 |
| Pfizer | 1 | $20 |
| Urovant Sciences Inc | 1 | $18 |
| Dentsply IH AB | 1 | $17 |
| Cook Medical LLC | 1 | $14 |
| Innovative Medical Technologies, LLC | 3 | $0 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SpaceOAR VUE System - 10mL$1,508
- Da Vinci Surgical System$316
- REVI$147
- INTERSTIM$122
- BOTOX$122
- ORGOVYX$110
- AIRSEAL$105
How this compares
$4,780 in reported general payments places this provider in the 60th percentile of 225 urology providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 56 | $28,064 |
| GemtesaVibegron | 19 | $11,583 |
| Silodosin | 136 | $6,677 |
| Tamsulosin Hcl | 128 | $1,720 |
| Finasteride | 182 | $1,516 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 97 | $1,050 |
| Potassium Citrate ErPotassium Citrate | 11 | $1,002 |
| Solifenacin Succinate | 19 | $581 |
| Tadalafil | 17 | $529 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 57 | $501 |
| Cefadroxil | 69 | $247 |
| Dutasteride | 13 | $180 |
| Levofloxacin | 86 | $147 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 21 | $70 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $173 | $28,06456 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $63 | $11,58319 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 225 urology providers in Colorado.
Other urology in Avon
- David CahnGolden$12.1M
- Lawrence KarshDenver$9.7M
- Alexandra RogersLafayette$541K
- Derek ZukoskyGolden$442K
- Paul MaroniAurora$234K
- James McBrideDurango$234K
- James FagelsonLittleton$229K
- Damian SorceParker$224K
- Michael FerrandinoWestminster$194K
- Brian FlynnAurora$176K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.